Edition:
United States

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

1.24USD
15 Jun 2018
Change (% chg)

$-0.03 (-2.36%)
Prev Close
$1.27
Open
$1.24
Day's High
$1.27
Day's Low
$1.22
Volume
17,050
Avg. Vol
29,746
52-wk High
$2.64
52-wk Low
$1.02

Chart for

About

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The... (more)

Overall

Beta: 1.01
Market Cap(Mil.): $73.58
Shares Outstanding(Mil.): 59.34
Dividend: --
Yield (%): --

Financials

  GNMX.OQ Industry Sector
P/E (TTM): -- 240.92 34.18
EPS (TTM): -0.72 -- --
ROI: -136.07 -5.87 13.17
ROE: -136.07 -7.71 15.15

BRIEF-Aevi Genomic Medicine Q1 Loss Per Share $0.15

* AEVI GENOMIC MEDICINE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

May 15 2018

BRIEF-Aevi Genomic Medicine Files For Mixed Shelf Of Up To $50 Mln

* AEVI GENOMIC MEDICINE INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Source text: (https://bit.ly/2IjWI5B) Further company coverage:

May 15 2018

BRIEF-Aevi Genomic Medicine Files Prospectus Supplement Related To Offering Of Common Stock

* AEVI GENOMIC MEDICINE INC FILES PROSPECTUS SUPPLEMENT RELATED TO OFFERING OF UP TO $20 MILLION CO'S COMMON STOCK - SEC FILING Source text: (https://bit.ly/2wHEyJD) Further company coverage:

May 15 2018

BRIEF-Aevi Genomic Medicine Reports Q4 Loss Per Share $0.13

* AEVI GENOMIC MEDICINE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Mar 13 2018

BRIEF-Aevi Genomic Medicine Expands Collaboration With Kyowa Hakko Kirin Co

* AEVI GENOMIC MEDICINE INC - EXPANDED COLLABORATION WITH KYOWA HAKKO KIRIN CO LTD

Mar 07 2018

Competitors

Earnings vs. Estimates